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ABSTRACr The plaque development of Herpes simplex virus type 1 (HSV) is slower for
viruses treated with two anti-DNA agents: ultraviolet radiation (UV) or n-acetoxy-2-
acetyl-aminofluorene. For HSV treated with three antimembrane agents-butylated hydroxy-
toluene, acridine plus near UV radiation, or ether-the plaque development time is the same
as for untreated viruses. These differences hold even for viruses that survived treatment that
lowered viability below the 1% level. Gamma ray inactivation of HSV produces no change in
plaque development even though this agent is believed to preferentially affect viral DNA.
In 1971 Ross et al. reported a "small plaque effect" (SPE) when ultraviolet (UV) irradiated
Herpes simplex virus (HSV) was assayed on mammalian cell cultures. This response was dose
dependent, virus dependent, and was characterized by the appearance of plaques produced by
UV irradiated HSV that were smaller than controls (unirradiated HSV). Further studies
showed that this effect was wavelength dependent (Cameron, 1973) and could be attributed
to a delay time required for the initiation of virus plaques (Ross et al., 1972). After this delay
the surviving virus produced plaques at the same rate as unirradiated virus (Ross et al., 1972).
The SPE appeared to be unaffected by agents which inhibit host-cell reactivation but was
reversed by photoreactivation (Ross et al., 1972). It follows that the lesions causing the delay
are most likely in the viral nucleic acid. Cameron (1975) has reviewed these findings. Our
interest in this phenomenon is to make use of the SPE to determine the potential risks of using
various antiviral agents. It is reasoned that only those agents that attack viral nucleic acid
(and thus cause damage that may delay viral synthesis) should give a SPE. Virucidal agents
that act on other viral components (e.g., membranes) should not give rise to such a delay.
Nucleic acid damage (and its possible repair) can lead to mutagenesis (Radman, 1975) and
mutagenesis to carcinogenesis (Trosko and Chang, 1977).
Reported below are the results of treatment with various antiviral agents on HSV plaque
development in mammalian cells. We tested three anti-DNA agents (UV, -y rays, n-
acetoxy-2-acetylaminofluorene [AAAF] [Roberts, 1978]) and three agents that act on viral
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membranes (butylated hydroxytoluene [BHT] [Snipes et al., 1975], acridine plus near UV
[Snipes et al. 19791, ether [Andrewes and Horstmann, 1949]). The antimembrane agents
tested have been shown by these authors to inactivate enveloped viruses at concentrations and
under conditions where lipid free viruses are not affected. No definite grouping of risk
potential is apparent for the list of agents used. However, the results suggest that the SPE may
measure the degree of reparability of damaged virus.
Details of the procedures for growing mammalian cells and viruses, for virus assay by
plaque development, and for viral exposure to UV radiation are as previously described
(Coohill et al., 1978). Freshly confluent monolayers of African green monkey kidney cells
(line CV-1) in 60-mm plastic petri dishes (Lux, Newbury Park, Calif.) were used for viral
assay. HSV-1 macroplaque (MP) strain was the virus used in all of these studies (Hoggan and
Roizman, 1959). For UV studies an 8-W General Electric G8T5 germicidal lamp (General
Electric Co., Wilmington, Mass.) was placed 10 cm from a suspension of viruses in phosphate
buffered saline (PBS). The principal output of this source is at 254 nm. Exposure rates were
determined using a UV-sensitive photovoltaic cell (Jagger meter [Jagger, 1967]). For
treatment with AAAF viruses were placed in 0.9 ml PBS and AAAF in 10% dimethyl
sulfoxide was added in a 0.1 ml aliquot. For -y ray inactivation, viruses were placed in
Dulbecco's MEM (Flow Laboratories, Rockville, Md.) and irradiated in a Co6o source at a
TABLE I
HERPES SIMPLEX VIRUS PLAQUE DIAMETER AFTER ANTIVIRAL TREATMENT
AntiviraatInactivation level
Ratio of treated
Antiviral agent Treatment
as percent survival virus plaque size
to untreated controls
Anti-DNA agents
UV (254 nm) lOOJ m-2 4.0 0.50
350 J m-2 1.0 0.48
450 J m-2 0.4 0.45
800 J m-2 0.1 0.46
1200 J m 2 0.02 0.44
AAAF 80,ug/ml 4.0 0.87
100,ug/ml 1.0 0.77
125,ug/ml 0.2 0.73
150,ug/ml 0.02 0.79
y rays (Co60) 100 krad 3.0 0.91
150 krad 1.0 0.96
200 krad 0.05 1.02
Antimembrane agents
Acridine, near UV exposure*
(25 lig/ml) 1.0 min 4.0 0.96
1.5 min 1.0 1.01
2.0 min 0.1 0.99
BHT 1 5-min exposure 1.0 mm 1.0 1.06
1.5 mm 0.4 0.98
Ether 6% . 1.0 0.92
7% 0.05 1.08
9% 0.01 0.95
*See text and Snipes et al. (1979).
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dose rate of 15 krad/min. BHT inactivation was as described by Snipes et al. (1975). Acridine
plus near UV light inactivation was as by Snipes et al. (1979). Viral inactivation by ether was
accomplished by adding the appropriate percentage of ether into a viral suspension in PBS.
The exposures for each treatment are listed in Table I.
After viral exposure and appropriate dilution, the viruses were inoculated onto CV-1 cell
monolayers in growth medium (DMEM plus 10% fetal bovine serum [Grand Island
Biological Co., Grand Island, N.Y.]). After an adsorption period of 90 min at 370C in a 5%
C02-air atmosphere, the viral inoculum was removed and replaced with 3 ml of growth
medium containing 0.25% immune serum globulin to prevent extracellular viral transfer.
Plaques were allowed to develop for 48 h after viral transfer. Plaques were allowed to develop
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FIGURE 1 Histograms of HSV-MP plaque sizes on CV- 1 cells. (a) Virus treated with varying amounts of
254-nm UV radiation. S, per cent survival measured by pfa. d, the average plaque diameter in millimeters
including a measure of the standard deviation. (b) Virus treated with other virucidal agents: control-
untreated virus; 6% ether for 15 min; 150 krad of Co'0 y rays; 25 Ag/ml of acridine plus 1.5 min of near
UV radiation (360 nm); 1 mM BHT for 15 min; 100 gg/ml ofAAAF for 15 min. All virus was inactivated
to the 1% survival level. In both a and b the ordinate is the percentage of total plaques of a given diameter.
The abscissa is the average group diameter (i.e., 1.0 refers to plaques ranging in diameter from 0.75 to
1.24 mm). 120 plaques were counted for each histogram.
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for 48 h after viral inoculation, then the growth medium was removed and the cells stained
with 1% crystal violet. Plaque sizes were determined as previously reported (Coohill, et al.,
1979) by projecting an enlarged image of the monolayer onto a sheet of paper. Typical plaque
size distributions are noted in Fig. 1 and are presented as the unmagnified plaque diameter.
Fig. 1 shows that UV radiation causes HSV-MP to give rise to small plaques as was
reported for HSV- 1 and HSV-2 by Ross et al. (1971). A dose response for this effect is shown.
Fig. 1 also shows that ether, y rays, BHT, and acridine plus light do not give a SPE at the 1%
survival level whereas AAAF does. Table I lists those agents that have been tested for the SPE
and shows the range of data collected. In each case virus was isolated from small plaques and
reassayed on unirradiated cells. These cloned viruses produced plaques of normal size, that is,
small plaques are not due to mutations (Cameron, 1975). Plaque size had no apparent effect
on plaque morphology when observed at a magnification of x 40.
The results illustrated in Fig. 1 show that all three antimembrane agents (BHT, ether and
acridine plus light) do not give rise to the SPE. It is presumed that inactivation of the viral
lipid envelope by these compounds gives rise to two classes of viral particles: those that are
inactivated and those that survive. These results show that the surviving virions are equivalent
to untreated virus in plaque development timing. UV and AAAF, two anti-DNA agents, give
rise to the SPE. It is assumed here that a percentage of the surviving virions were delayed in
plaque development presumably due to repair. This delay can cause the observed SPE (Ross
et al., 1972). Note that the amount of SPE was less for AAAF treated viruses. The results
involving 'y-ray inactivation are not easily interpreted. Gamma rays apparently can cause
nucleic acid damage to HSV (Powell, 1959). However, Cameron (1975) has pointed out that
there is very little information on the molecular changes induced by y-irradiation of
extracellular virus. He also reported that HSV inactivated with electron bombardment did not
give a SPE (Cameron, 1975). It would appear from our data that after Y-ray treatment the
surviving virions are not hindered in beginning plaque development at the same time as
untreated virus. This is true even for viruses inactivated to the 0.05% survival level (see Table
I). Whether these data argue that y-ray damage to HSV is unrepairable by the cell or is
repaired immediately to unknown.
These results suggest that the SPE is a rapid (2 d) and reliable (consistent data for each
agent) assay for a virus's response to inactivating agents. Whether the SPE measures the
degree of repairability and hence mutagenicity of damaged viruses awaits further experimen-
tation involving a mutational assay for HSV.
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